Business Practice

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Nominations are now open for The Medicine Maker 2020 Power List.

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

We are delighted to announce that The Medicine Maker Power List 2019 is here!

The evolving Brexit landscape provides ample opportunities for companies to position themselves as leaders and influencers.

Sitting Down With… Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre (MMIC), Scotland, UK.

Research and development tax reliefs are available for businesses in many countries, but some companies are not taking advantage.